DCF — PIKEVILLE MEDICAL CENTER
Enterprise Value: $-1.4B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.4B
Enterprise Value
$-429.8M
PV of Cash Flows
$-960.5M
PV of Terminal Value
$-1.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $571.8M | $-92.1M | -16.0% | $-116.3M | $-105.7M |
| Year 2 | $589.0M | $-89.0M | -15.0% | $-113.9M | $-94.1M |
| Year 3 | $606.6M | $-85.6M | -14.0% | $-111.2M | $-83.6M |
| Year 4 | $624.8M | $-85.0M | -14.0% | $-111.5M | $-76.1M |
| Year 5 | $643.6M | $-85.9M | -13.0% | $-113.2M | $-70.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.4B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$555.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16604175314814715
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5